Atlas Venture Life Science Advisors, LLC / KYMR
Atlas Venture Life Science Advisors, LLC’s Kymera Therapeutics Inc Position
Does Atlas Venture Life Science Advisors, LLC own Kymera Therapeutics Inc (KYMR)? Yes — 4.58M shares worth $381M (+48.26% of its 13F portfolio) as of Q1 2026, down from 4.66M shares the prior filed quarter.
Position Value
$381M
Q1 2026
Shares
4.58M
% of Portfolio
+48.26%
Quarters Held
17
currently held
Position History KYMR
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 4.58M | $381M | +48.26% |
| Q4 2025 | 4.66M | $363M | +41.91% |
| Q3 2025 | 4.90M | $277M | +36.82% |
| Q2 2025 | 4.90M | $214M | +32.26% |
| Q1 2025 | 4.90M | $134M | +25.69% |
| Q4 2024 | 4.90M | $197M | +24.03% |
| Q3 2024 | 4.90M | $232M | +21.48% |
| Q2 2024 | 5.35M | $160M | +16.82% |
| Q1 2024 | 5.38M | $216M | +19.95% |
| Q4 2023 | 5.86M | $149M | +17.76% |
| Q3 2023 | 5.86M | $81M | +12.61% |
| Q2 2023 | 5.86M | $135M | +16.76% |
| Q1 2023 | 5.86M | $174M | +23.50% |
| Q4 2022 | 5.98M | $149M | +17.99% |
| Q3 2022 | 6.88M | $150M | +16.52% |
| Q2 2022 | 6.88M | $135M | +22.63% |
| Q1 2022 | 6.88M | $291M | +36.79% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Atlas Venture Life Science Advisors, LLC’s full portfolio or all institutional holders of KYMR.